Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 9
Submit an article Journal homepage
3,212
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Online information discrepancies regarding safety of medicine use during pregnancy and lactation: an IMI ConcePTION study

Ulrika Nörbya Department of Knowledge Development, Health and Medical Care Administration, Region Stockholm, SwedenCorrespondence[email protected]
View further author information
,
Benedikte Noël-Cuppersb Teratology Information Service, Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, The NetherlandsView further author information
,
Sashka Hristoskovac Global Medical Affairs, Innovative Medicines division, Novartis Pharma AG, Basel, SwitzerlandView further author information
,
Monali Desaid Patient Safety and Pharmacovigilance, Abbvie, NorthChicago, IL, USAView further author information
,
Linda Härmarkb Teratology Information Service, Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, The NetherlandsView further author information
,
Michael Steele Chief Medical Office, Global Drug Development, Novartis Pharma AG, Basel, SwitzerlandView further author information
,
Chantal El-Haddadf Epidemiology & Benefit–Risk, Global Pharmacovigilance, Sanofi, Chilly-Mazarin, FranceView further author information
&
Ludivine Douarinf Epidemiology & Benefit–Risk, Global Pharmacovigilance, Sanofi, Chilly-Mazarin, FranceView further author information
 show all
Pages 1117-1124 | Received 26 Jan 2021, Accepted 24 May 2021, Published online: 08 Jun 2021

References

  • Hämeen-Anttila K, Nordeng H, Kok ki E, et al., Multiple Information sources and consequences of conflicting information about medicine use during pregnancy: a multinational internet-based survey. J Med Internet Res. 16(2): e60. 2014.
  • Sinclair M, Lagan BM, Dolk H, et al. An assessment of pregnant women’s knowledge and use of the internet for medication safety information and purchase. J Adv Nurs. 2018;74:137–147. .
  • Brown E, Hotham E, Hotham N. Pregnancy and lactation advice: how does Australian product information compare with established information resources? Obstet Med. 2016;9:130.
  • Ververs T, van Dijk L, Yousofi S, et al. Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists. BMC Health Serv Res. 2009 july 17;9:119. .
  • Schaefer C, Hannemann D, Meister R. Post-marketing surveillance system for drugs in pregnancy—15 years experience of ENTIS. Reprod Toxicol. 2005;20:331–343.
  • Hancock RL, Koren G, Einarson A, et al. The effectiveness of Teratology Information Services (TIS). Reprod Toxicol. 2007;23:125–132.
  • Clementi M, Di Gianantonio E, Ornoy A. Teratology information services in Europe and their contribution to the prevention of congenital anomalies. Community Genet. 2002;5:8–12.
  • Nörby U, Källén K, Eiermann B, et al. Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers. Eur J Clin Pharmacol. 2013;69:889–899.
  • Frost Widnes SK, Schjøtt J. Advice on drug safety in pregnancy: are there differences between commonly used sources of information? Drug Saf. 2008;31:799–806. .
  • Warrer P, Aagaard L, Hansen EH. Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK. Drug Saf. 2014;37:805–813.
  • Gelder MMHJ, Rog A, Bredie SJH, et al. Social media monitoring on the perceived safety of medication use during pregnancy: a case study from the Netherlands. Br J Clin Pharmacol. 2019;85:2580–2590. .
  • Hansen C, Interrante JD, Ailes EC, et al. Assessment of YouTube videos as a source of information on medication use in pregnancy: youTube videos on medication use in pregnancy. Pharmacoepidemiol Drug Saf. 2016;25:35–44.
  • Palosse-Cantaloube L, Lacroix I, Rousseau V, et al. Analysis of chats on French internet forums about drugs and pregnancy: drugs and pregnancy related online conversations. Pharmacoepidemiol Drug Saf. 2014;23:1330–1333.
  • Walfisch A, Sermer C, Matok I, et al. Perception of teratogenic risk and the rated likelihood of pregnancy termination: association with maternal depression. Can J Psychiatry. 2011;56:761–767.
  • Theurich MA, Davanzo R, Busck-Rasmussen M, et al. Breastfeeding rates and programs in europe: a survey of 11 national breastfeeding committees and representatives. J Pediatr Gastroenterol Nutr. 2019;68:400–407.
  • Czarska-Thorley D. Updated restrictions for Gilenya: multiple sclerosis medicine not to be used in pregnancy [Internet]. Eur Med Agency 2019. Accessed 2020 May 29. https://www.ema.europa.eu/en/news/updated-restrictions-gilenya-multiple-sclerosis-medicine-not-be-used-pregnancy
  • Michie LA, Hodson KK. Ondansetron for nausea and vomiting in pregnancy: re-evaluating the teratogenic risk. Obstet Med. 2020;13:3–4.
  • Peters SL, Lind JN, Humphrey JR, et al. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from web-based information, 2011: web safe lists for medications in pregnancy. Pharmacoepidemiol Drug Saf. 2013;22:324–328.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.